Zika Virus and the Blood Supply: What Do We Know?
- PMID: 27569055
- DOI: 10.1016/j.tmrv.2016.08.001
Zika Virus and the Blood Supply: What Do We Know?
Abstract
Zika virus (ZIKV), a mosquito-borne Flavivirus and emerging infectious disease, is the focus of an international public health emergency after its rapid spread through the Americas and the Caribbean. Although most ZIKV infections are subclinical or characterized by mild febrile illness, ZIKV has been implicated in severe complications, most notably microcephaly in babies born to incident infected mothers during pregnancy. As yet, the extent to which ZIKV is transfusion transmissible remains undefined. Nonetheless, a high prevalence of asymptomatic infection during outbreaks, the demonstration of ZIKV in blood donors, and 4 possible cases of transfusion-transmitted ZIKV in Brazil have raised concern for risk to the blood supply. Consequently, a proactive response is underway by blood collection agencies, regulatory bodies, national funding agencies, and industry alike. Mitigation strategies differ between endemic and nonendemic areas. In the continental United States, the American Association of Blood Banks and Food and Drug Administration guidelines recommend travel-based deferral for those returning from affected areas, and nucleic acid testing is being initiated under an investigational new drug application in Puerto Rico and selected areas of the United States. Options are less clear for countries where autochthonous vector-borne transmission is active. The burden of Zika falls in low-resource countries where high cost and technical barriers associated with testing and pathogen reduction pose barriers to implementation. Additional strategies include maintaining selective inventory for high-risk recipients (eg, pregnant women). We review the available data as of July 2016 on ZIKV in relation to the blood supply including risk, mitigation strategies, and barriers to implementation in addition to the research that is needed to address current uncertainty.
Keywords: Arbovirus; Blood safety; Blood transfusion; Communicable diseases; Emerging; Transfusion-transmitted virus; Zika virus.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Zika Virus and Patient Blood Management.Anesth Analg. 2017 Jan;124(1):282-289. doi: 10.1213/ANE.0000000000001770. Anesth Analg. 2017. PMID: 27902502 Review.
-
Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus.Med J Aust. 2017 Jun 5;206(10):455-460. doi: 10.5694/mja16.00833. Med J Aust. 2017. PMID: 28566073 Review.
-
Estimation of mosquito-borne and sexual transmission of Zika virus in Australia: Risks to blood transfusion safety.PLoS Negl Trop Dis. 2020 Jul 14;14(7):e0008438. doi: 10.1371/journal.pntd.0008438. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32663213 Free PMC article.
-
Zika virus: an emerging challenge to public health worldwide.Can J Microbiol. 2020 Feb;66(2):87-98. doi: 10.1139/cjm-2019-0331. Epub 2019 Nov 4. Can J Microbiol. 2020. PMID: 31682478 Review.
-
Zika and the Blood Supply: A Work in Progress.Arch Pathol Lab Med. 2017 Jan;141(1):85-92. doi: 10.5858/arpa.2016-0430-RA. Epub 2016 Oct 27. Arch Pathol Lab Med. 2017. PMID: 27788336
Cited by
-
Immunosuppression-induced Zika virus reactivation causes brain inflammation and behavioral deficits in mice.iScience. 2024 Jun 5;27(7):110178. doi: 10.1016/j.isci.2024.110178. eCollection 2024 Jul 19. iScience. 2024. PMID: 38993676 Free PMC article.
-
Fetal Rhesus Monkey First Trimester Zika Virus Infection Impacts Cortical Development in the Second and Third Trimesters.Cereb Cortex. 2021 Mar 31;31(5):2309-2321. doi: 10.1093/cercor/bhaa336. Cereb Cortex. 2021. PMID: 33341889 Free PMC article.
-
Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases.Transfus Med Rev. 2023 Oct;37(4):150769. doi: 10.1016/j.tmrv.2023.150769. Epub 2023 Oct 4. Transfus Med Rev. 2023. PMID: 37919210 Free PMC article.
-
Impact of Zika virus for infertility specialists: current literature, guidelines, and resources.J Assist Reprod Genet. 2017 Oct;34(10):1237-1250. doi: 10.1007/s10815-017-0988-1. Epub 2017 Jul 7. J Assist Reprod Genet. 2017. PMID: 28687969 Free PMC article. Review.
-
Molecular Approaches for the Validation of the Baboon as a Nonhuman Primate Model for the Study of Zika Virus Infection.Front Cell Infect Microbiol. 2022 Apr 14;12:880860. doi: 10.3389/fcimb.2022.880860. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35493734 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials